Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 4.68%-334.36K | 27.30%-295.15K | 28.06%-1.34M | -314.87K | 21.45%-266.24K | 23.76%-350.78K | 17.88%-405.96K | -1.86M | 29.86%-338.96K | 28.32%-460.09K |
| Net income from continuing operations | 52.47%-294.75K | 42.35%-398.04K | -159.38%-2.61M | ---624.44K | 16.99%-671.66K | -128.86%-620.09K | 27.81%-690.38K | ---1M | 27.66%-809.08K | 362.61%2.15M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---2.97M | --0 | ---- |
| Depreciation and amortization | -0.63%51.66K | -0.62%51.66K | -45.21%207.95K | --51.99K | 27.21%51.99K | 27.21%51.99K | 27.21%51.99K | --379.56K | -26.76%40.87K | -27.77%40.87K |
| Asset impairment expenditure | -1,052.36%-73.8K | -720.27%-26.25K | -229.68%-151.49K | ---163.01K | ---459 | --7.75K | --4.23K | --116.82K | ---- | ---- |
| Remuneration paid in stock | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --2.15K | ---- | ---- |
| Remuneration paid in stock | -31.18%81.16K | -82.29%23.82K | 107.77%567.49K | --219.87K | 319.07%95.21K | 167.07%117.92K | 145.44%134.49K | --273.13K | -20.43%22.72K | 175.30%44.16K |
| Other non cashItems | ---- | ---- | -12.95%33.1K | --0 | 100.00%-1 | 367.54%16.82K | -23.99%16.27K | --38.02K | -257.64%-32.89K | 101.87%3.6K |
| Change In working capital | -231.80%-98.63K | -30.72%53.65K | -53.17%611.67K | --200.72K | -22.82%258.68K | -68.22%74.83K | -77.40%77.44K | --1.31M | -33.58%335.14K | -13.39%235.45K |
| -Change in receivables | -46.96%19.16K | -144.65%-17.55K | -79.39%82.62K | ---14.01K | -57.67%21.19K | 831.15%36.12K | 188.42%39.32K | --400.93K | 382.49%50.06K | -176.26%-4.94K |
| -Change in prepaid assets | 38.13%-30.49K | 153.59%5.19K | -101.57%-413 | --4.26K | 1,868.92%42.57K | -548.16%-49.28K | 105.61%2.05K | --26.36K | -48.35%2.16K | 140.74%11K |
| -Change in payables and accrued expense | -199.20%-87.29K | 82.99%66.02K | -43.39%529.47K | --210.47K | -1.38%194.92K | -48.08%88K | -88.12%36.08K | --935.34K | -42.89%197.64K | -13.50%169.49K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---56.43K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 4.68%-334.36K | 27.30%-295.15K | 28.06%-1.34M | ---314.87K | 21.45%-266.24K | 23.76%-350.78K | 17.88%-405.96K | ---1.86M | 29.86%-338.96K | 28.32%-460.09K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 0 | 0 | 25K | 0 | 0 | ||
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --0 |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --25K | ---- | ---- |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --25K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --25K | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 76.80%730.75K | -16.50%300.57K | -30.08%1.29M | 213.71K | -6.73%304.71K | 2.95%413.31K | -33.25%359.96K | 1.85M | -28.19%326.68K | -36.92%401.48K |
| Net issuance payments of debt | 1,145.17%118K | 346.48%285.57K | -29.18%326.09K | --103.71K | 2,368.85%169.71K | -104.68%-11.29K | -74.10%63.96K | --460.42K | -101.64%-7.48K | 63.07%241.39K |
| Net common stock issuance | 29.11%612.75K | -93.90%15K | -28.84%965.6K | --190K | -83.54%55K | 196.46%474.6K | -15.85%246K | --1.36M | --334.16K | -67.22%160.09K |
| Proceeds from stock option exercised by employees | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --30K | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | --50K | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 76.80%730.75K | -16.50%300.57K | -30.08%1.29M | --213.71K | -6.73%304.71K | 2.95%413.31K | -33.25%359.96K | --1.85M | -28.19%326.68K | -36.92%401.48K |
| Net cash flow | ||||||||||
| Beginning cash position | 49.65%15.85K | -81.57%10.43K | 28.61%56.6K | --111.59K | 141.43%73.13K | -88.08%10.59K | 28.61%56.6K | --44.01K | -81.76%30.29K | -48.80%88.9K |
| Current changes in cash | 533.91%396.39K | 111.78%5.42K | -466.63%-46.16K | ---101.16K | 413.33%38.47K | 206.69%62.53K | -202.47%-46K | --12.59K | 56.66%-12.28K | -678.84%-58.61K |
| End cash Position | 463.75%412.25K | 49.65%15.85K | -81.57%10.43K | --10.43K | 519.58%111.59K | 141.43%73.13K | -88.08%10.59K | --56.6K | -86.93%18.01K | -81.76%30.29K |
| Free cash from | 4.68%-334.36K | 27.30%-295.15K | 28.06%-1.34M | ---314.87K | 21.45%-266.24K | 23.76%-350.78K | 17.88%-405.96K | ---1.86M | 29.86%-338.96K | 28.55%-460.09K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.